MMP9 and precursor B-cell acute lymphoblastic leukemia: In contrast, a significantly reduced BCR-ABL1+ (GFP+) BP-1+ leukemia load (P = 0.003, Fig. 1a), as well as prolonged survival (P = 0.001, Fig. 1b) was observed in MMP-9-deficient mice with B-ALL.